Medigene AG
MDG1
Helyezés a részvények között
#35250
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
Részvényárfolyam
$0.14942078
Utolsó szinkronizálás: 2025-05-15
Piaci kapitalizáció
$3.86M
Változás (1 nap)
0.10%
Változás (1 év)
47.84%
Ország
DE
Kereskedés Medigene AG (MDG1)
Kategória
Healthcare
Medigene AG (MDG1) részvényárfolyamának története
Legmagasabb napi záróár: $0.34 ekkor: 2025-04-01
Legalacsonyabb napi záróár: $61.30 ekkor: 2007-12-01
Legalacsonyabb napi záróár: $61.30 ekkor: 2007-12-01
Medigene AG részvényárfolyamának története 2007 és 2026 között
Éves részvényárfolyam teljesítmény
| Év | Teljesítmény |
|---|---|
| 2025 | -69.63% |
| 2024 | -62.74% |
| 2023 | -33.26% |
| 2022 | -26.38% |
| 2021 | -24.98% |
| 2020 | -21.07% |
| 2019 | -42.42% |
| 2018 | -38.07% |
| 2017 | 37.11% |
| 2016 | 29.60% |
| 2015 | 57.57% |
| 2014 | 2.53% |
| 2013 | -8.47% |
| 2012 | -42.08% |
| 2010 | -54.73% |
| 2009 | -11.17% |
| 2008 | -21.76% |
| 2007 | 0.00% |
Hasonló cégek vagy versenytársak részvényárai
| Vállalat | Részvényár | Változás 1év% | Ország |
|---|---|---|---|
| $536.13 | 25.72% |
US
|
|
| $200.12 | 645.31% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $880.01 | 8.09% |
NL
|
